SUPPLEMENT TO DFCI CANCER CENTER SUPPORT GRANT
DFCI 癌症中心支持补助金的补充
基本信息
- 批准号:2690586
- 负责人:
- 金额:$ 33.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1977
- 资助国家:美国
- 起止时间:1977-12-01 至 2000-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The Dana-Farber Cancer Institute is an independent teaching affiliate of
the Harvard Medical School and supports a federally-designated
Comprehensive Cancer Center. The aims of the Institute's Center can be
summarized as follows:
(a) to develop and maintain clinical and laboratory research programs of
high quality related to the biology, cause and prevention, diagnosis and
treatment of cancer.
(b)to serve as the major cancer center in the Harvard-Longwood medical area
and to play a leadership role for cancer research in New England providing
expertise in cancer diagnosis, treatment and prevention.
(c) to participate in the research training of medical students, house
staff, fellows and graduate students and to provide post-doctoral research
training.
To maintain these activities, the present application requests renewal of
the Institute's Cancer Core Support Grant.
In addition, as a Comprehensive Cancer Center, the institute aims to
translate its research findings to provide optimal care for cancer patients
and to add to the total oncology resources of the local and regional
medical communities in terms of staff, facilities and expertise.
丹娜-法伯癌症研究所是一个独立的教学附属机构
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID G. NATHAN其他文献
Comparative Metabolism of Hæmoglobins A and F in Thalassæmia
- DOI:
10.1038/196781b0 - 发表时间:
1962-11-24 - 期刊:
- 影响因子:48.500
- 作者:
THOMAS G. GABUZDA;DAVID G. NATHAN;FRANK H. GARDNER - 通讯作者:
FRANK H. GARDNER
DAVID G. NATHAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID G. NATHAN', 18)}}的其他基金
CORRECTION OF CONGENITAL DISEASES BY STEM CELL THERAPY
通过干细胞疗法纠正先天性疾病
- 批准号:
6660967 - 财政年份:2002
- 资助金额:
$ 33.71万 - 项目类别:
CORRECTION OF CONGENITAL DISEASES BY STEM CELL THERAPY
通过干细胞疗法纠正先天性疾病
- 批准号:
6500773 - 财政年份:2001
- 资助金额:
$ 33.71万 - 项目类别:
CORRECTION OF CONGENITAL DISEASES BY STEM CELL THERAPY
通过干细胞疗法纠正先天性疾病
- 批准号:
6358511 - 财政年份:2000
- 资助金额:
$ 33.71万 - 项目类别:
CORRECTION OF CONGENITAL DISEASES BY STEM CELL THERAPY
通过干细胞疗法纠正先天性疾病
- 批准号:
6202406 - 财政年份:1999
- 资助金额:
$ 33.71万 - 项目类别:
CORRECTION OF CONGENITAL DISEASES BY STEM CELL THERAPY
通过干细胞疗法纠正先天性疾病
- 批准号:
6110518 - 财政年份:1998
- 资助金额:
$ 33.71万 - 项目类别:
ROLE OF HEMATOPOIETIC GROWTH FACTORS AND THEIR RECEPTORS DURING HEMATOPOIESIS
造血生长因子及其受体在造血过程中的作用
- 批准号:
6236732 - 财政年份:1997
- 资助金额:
$ 33.71万 - 项目类别:
CORRECTION OF CONGENITAL DISEASES BY STEM CELL THERAPY
通过干细胞疗法纠正先天性疾病
- 批准号:
6242512 - 财政年份:1997
- 资助金额:
$ 33.71万 - 项目类别:
STEM CELL THERAPY OF CONGENITAL DEFECTS IN HEMATOPOIESIS
先天性造血缺陷的干细胞治疗
- 批准号:
6389508 - 财政年份:1995
- 资助金额:
$ 33.71万 - 项目类别:
STEM CELL THERAPY OF CONGENITAL DEFECTS IN HEMATOPOIESIS
先天性造血缺陷的干细胞治疗
- 批准号:
6527036 - 财政年份:1995
- 资助金额:
$ 33.71万 - 项目类别:
STEM CELL THERAPY OF CONGENITAL DEFECTS IN HEMATOPOIESIS
先天性造血缺陷的干细胞治疗
- 批准号:
2519518 - 财政年份:1995
- 资助金额:
$ 33.71万 - 项目类别:
相似海外基金
Integrating Competing Risks into the CISNET DFCI Breast Cancer Model
将竞争风险整合到 CISNET DFCI 乳腺癌模型中
- 批准号:
8753097 - 财政年份:2014
- 资助金额:
$ 33.71万 - 项目类别:














{{item.name}}会员




